Assignee
INTELLIKINE LLC
US·19 granted patents·22 pending applications·191 citations·filing 2012–2025
Top patents by PatentIndex Score
41 records- 0197US9359349B2Substituted quinazolines as kinase inhibitorsINTELLIKINE LLC·Filed 2014·Granted Jun 7, 2016·56 cites·9 claims
- 0297US9315505B2Heterocyclic compounds and uses thereofINTELLIKINE LLC·Filed 2014·Granted Apr 19, 2016·64 cites·18 claims
- 0394US9522146B2Substituted Isoquinolin-1(2H)-one compounds, compositions, and methods thereofINTELLIKINE LLC·Filed 2015·Granted Dec 20, 2016·10 cites·24 claims
- 0491US9669032B2Enhanced treatment regimens using mTOR inhibitorsINTELLIKINE LLC·Filed 2015·Granted Jun 6, 2017·13 cites·17 claims
- 0591US9216982B2Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2014·Granted Dec 22, 2015·8 cites·28 claims
- 0690US9206182B2Substituted isoquinolin-1(2H)-one compounds, compositions, and methods thereofINTELLIKINE LLC·Filed 2013·Granted Dec 8, 2015·8 cites·27 claims
- 0787US9828378B2Kinase inhibitors and methods of useINTELLIKINE LLC·Filed 2015·Granted Nov 28, 2017·6 cites·18 claims
- 0887US2024209000A1Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2023·Application pending·0 cites
- 0986US2026042780A1Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2025·Application pending·0 cites
- 1085US9296742B2Heterocyclic kinase inhibitorsINTELLIKINE LLC·Filed 2014·Granted Mar 29, 2016·6 cites·22 claims
- 1185US9174994B2Enhanced treatment regimens using mTor inhibitorsINTELLIKINE LLC·Filed 2012·Granted Nov 3, 2015·9 cites·21 claims
- 1281US9682141B2Combination of kinase inhibitors and uses thereofINTELLIKINE LLC·Filed 2012·Granted Jun 20, 2017·5 cites·4 claims
- 1380US9345706B2Benzoxazole kinase inhibitors and methods of useINTELLIKINE LLC·Filed 2015·Granted May 24, 2016·1 cites·1 claims
- 1480US2022265637A1Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2021·Application pending·0 cites
- 1580US2025170122A1Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2025·Application pending·0 cites
- 1678US9655892B2Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2015·Granted May 23, 2017·1 cites·21 claims
- 1778US9637492B2Benzothiazole kinase inhibitors and methods of useINTELLIKINE LLC·Filed 2015·Granted May 2, 2017·2 cites·19 claims
- 1877US11433065B2Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2019·Granted Sep 6, 2022·0 cites·16 claims
- 1974US2022372048A1Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2020·Application pending·0 cites
- 2073US9790228B2Heterocyclic kinase inhibitorsINTELLIKINE LLC·Filed 2016·Granted Oct 17, 2017·1 cites·10 claims
- 2171US9403820B2Kinase inhibitor polymorphsINTELLIKINE LLC·Filed 2012·Granted Aug 2, 2016·1 cites·9 claims
- 2271US2019290636A1Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2018·Application pending·0 cites
- 2367US2018098983A1Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2017·Application pending·0 cites
- 2466US2016287596A1Benzoxazole Kinase Inhibitors and Methods of UseINTELLIKINE LLC·Filed 2016·Application pending·0 cites
- 2565US2017281614A1Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2016·Application pending·0 cites
- 2664US2018258103A1Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2017·Application pending·0 cites
- 2764US2014206684A1Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2014·Application pending·0 cites
- 2861US9822131B2Certain chemical entities, compositions and methodsINTELLIKINE LLC·Filed 2016·Granted Nov 21, 2017·0 cites·10 claims
- 2960US10172858B2Combination pharmaceutical compositions and uses thereofINTELLIKINE LLC·Filed 2016·Granted Jan 8, 2019·0 cites·8 claims
- 3060US2018042902A1Heterocyclic Compounds and Uses ThereofINTELLIKINE LLC·Filed 2017·Application pending·0 cites
- 3157US2014350248A1Chemical entities and therapeutic uses thereofINTELLIKINE LLC·Filed 2013·Application pending·0 cites
- 3257US2015087627A1Combination of kinase inhibitors and uses thereofINTELLIKINE LLC·Filed 2014·Application pending·0 cites
- 3354US2015320727A1Heterocyclic compounds and uses thereofINTELLIKINE LLC·Filed 2015·Application pending·0 cites
- 3453US2016089371A1Combination of Kinase Inhibitors and Uses ThereofINTELLIKINE LLC·Filed 2014·Application pending·0 cites
- 3552US2014377285A1Treatment regimens using multiple pharmaceutical agentsINTELLIKINE LLC·Filed 2012·Application pending·0 cites
- 3650US2017209448A1Treatment regimens using multiple pharmaceutical agentsINTELLIKINE LLC·Filed 2017·Application pending·0 cites
- 3749US2016235758A1Combination of mtor inhibitors and pi3-kinase inhibitors, and uses thereofINTELLIKINE LLC·Filed 2016·Application pending·0 cites
- 3848US2016287597A1Treatment Regimens Using Multiple Pharmaceutical AgentsINTELLIKINE LLC·Filed 2016·Application pending·0 cites
- 3945US9359352B2Substituted benzimidazoles as PI3 kinase inhibitorsINTELLIKINE LLC·Filed 2015·Granted Jun 7, 2016·0 cites·21 claims
- 4044US2014323721A1Heterocyclic compounds and uses thereofINTELLIKINE LLC·Filed 2012·Application pending·0 cites
- 4144US2014066462A1Treatment of polycystic diseaseINTELLIKINE LLC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when INTELLIKINE LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →